High response rate to darbopoetin alfa in "low risk" MDS: Results of a phase II study.

被引：0
|
作者：
Mannone, L [1 ]
Gardin, C [1 ]
Quarre, MC [1 ]
Bernard, JF [1 ]
Giraudier, S [1 ]
Rosenthal, E [1 ]
Vassilief, D [1 ]
Hamza, F [1 ]
Park, S [1 ]
Kiladjian, JJ [1 ]
Vaultier, S [1 ]
Beyne-Rouzy, M [1 ]
Cheze, S [1 ]
Voilliat, L [1 ]
Agape, P [1 ]
Dreyfus, F [1 ]
Fenaux, P [1 ]
机构：
[1] GFM, Paris 13, France
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
69
引用
收藏
页码：24A / 24A
页数：1
相关论文
共 50 条
  • [31] Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II study.
    Stevens, C
    Rice, D
    Forster, K
    Liao, Z
    Guerrero, T
    Correa, A
    Vaporciyan, A
    Smythe, WR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 664S - 664S
  • [32] Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.
    Giaccone, Giuseppe
    Thompson, Jillian
    McGuire, Colleen
    Manning, Maria
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Subramaniam, Deepa Suresh
    Liu, Stephen V.
    Gibney, Geoffrey Thomas
    Kim, Chul
    McCutcheon, Justine N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM
    C. Kelaidi
    O. Beyne-Rauzy
    T. Braun
    R. Sapena
    P. Cougoul
    L. Adès
    F. Pillard
    C. Lamberto
    J. C. Charniot
    A. Guerci
    B. Choufi
    A. Stamatoullas
    B. Slama
    B. De Renzis
    S. Ame
    G. Damaj
    F. Boyer
    M. P. Chaury
    L. Legros
    S. Cheze
    A. Testu
    E. Gyan
    M. C. Béné
    C. Rose
    F. Dreyfus
    P. Fenaux
    Annals of Hematology, 2013, 92 (5) : 633 - 633
  • [34] High complete response rate with TNB-486 in relapsed/refractory follicular lymphoma: Interim results from an ongoing phase 1 study.
    Nair, Ranjit
    Jacobs, Ryan
    Cho, Seok-Goo
    Devata, Sumana
    Gaballa, Sameh
    Yoon, Dok Hyun
    Stevens, Don A.
    Kim, Jin Seok
    Shah, Nirav Niranjan
    Brennan, Denise Marie
    Law, Jason
    Chen, Rob
    Forcina, Alessandra
    Buelow, Ben
    Hou, Jing-Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] A therapeutic vaccine for nicotine dependence: Results of a phase I and a randomized phase II study.
    Cornuz, J
    Klingler, K
    Mueller, P
    Jungi, F
    Cerny, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 108S - 108S
  • [36] Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study
    Platzbecker, Uwe
    Germing, Ulrich
    Giagounidis, Aristoteles
    Goetze, Katharina
    Kiewe, Philipp
    Mayer, Karin Tina
    Ottmann, Oliver
    Radsak, Markus
    Wolff, Thomas
    Haase, Detlef
    Hankin, Monty
    Wilson, Dawn
    Zhang, Xiaosha
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Attie, Kenneth M.
    BLOOD, 2015, 126 (23)
  • [37] High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis
    Foeldvari, I
    Burgos-Vargas, R
    Thon, A
    Tuerck, D
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 1079 - 1083
  • [38] Trisenox® (arsenic trioxide) in patients with Myelodysplastic syndromes (MDS):: Preliminary results of a phase 1/2 study.
    Vey, N
    Dreyfus, F
    Guerci, A
    Fenaux, P
    Dombret, H
    Burnett, A
    Bosly, A
    Feremans, W
    Bowen, D
    Garzon, F
    BLOOD, 2003, 102 (11) : 422A - 423A
  • [39] Results of phase II clinical study of lenalidomide in Japanese patients with myelodysplastic syndrome (MDS)
    Harada, H.
    Watanabe, M.
    Suzuki, K.
    Yanagita, S.
    Suzuki, T.
    Yoshida, Y.
    Kimura, A.
    Tsudo, M.
    Takatoku, M.
    Ozawa, K.
    LEUKEMIA RESEARCH, 2009, 33 : S123 - S123
  • [40] Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study
    Langer, Christian
    Lengfelder, Eva
    Thiele, Juergen
    Kvasnicka, Hans M.
    Pahl, Heike L.
    Beneke, Heimo
    Schauer, Stefanie
    Gisslinger, Heinz
    Griesshammer, Martin
    HAEMATOLOGICA, 2005, 90 (10) : 1333 - 1338
12345